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Abstract
Osteoarthritis (OA) is a disease of the entire joint but the relationship between
pathological events in various joint tissues is poorly understood. We examined
concurrent changes in bone, cartilage, and synovium in a naturally occurring equine
model of joint degeneration. Joints (n = 64) were grossly assessed for palmar/plantar
osteochondral disease (POD) in racehorses that required euthanasia for unrelated
reasons and assigned a grade of 0 (n = 34), 1 (n = 17), 2 or 3 (n = 13) using a re-
cognized grading scheme. Synovium, cartilage, and subchondral bone were collected
for histological and gene expression analysis. Relations between POD grade, carti-
lage histological score, and gene expression levels were examined using one‐way
analysis of variance or Kruskal–Wallis test and Spearman's correlation coefficient
with corrections for multiple comparisons. Cartilage histological score increased in
joints with POD grade 1 (p = 0.002) and 2 or 3 (p < 0.001) compared to 0. At grade 1,
expression of COL1A1, COL2A1, and MMP1 increased and BGN decreased in
subchondral bone while expression of BGN and ACAN decreased in cartilage. These
changes further progressed at grades 2 and 3. POD grades 2 and 3 were associated
with decreased expression of osteoclast inhibitor OPG and increased markers of
cartilage degeneration (MMP13, COL1A1). Expression of the vascular endothelial
growth factor decreased with POD grade and negatively correlated with cartilage
histological score. Synovium showed no histological or transcriptomic changes re-
lated to pathology grade. Cartilage degeneration in POD is likely to be secondary to
remodeling of the subchondral bone. Limited activation of proinflammatory and
catabolic genes and moderate synovial pathology suggests distinct molecular
phenotype of POD compared with OA.
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1 | INTRODUCTION
Osteoarthritis (OA) is a chronic disease that can affect all joint tis-
sues. Major pathological changes observed in OA are degradation of
the articular cartilage, thickening or sclerosis of the subchondral
bone, synovial inflammation, and hypertrophy of the joint capsule.1,2
The structural changes in articular cartilage during OA result from
disruption of tissue homeostasis at the molecular level. OA is char-
acterized by the shift from extracellular matrix (ECM) synthesis to
catabolism, promoted by proinflammatory mediators that are re-
leased due to mechanical insult or individual risk factors; such as
obesity and ageing.3,4 Tissue degradation is followed by inadequate
repair response, involving chondrocyte hypertrophy5 and changes in
bone and cartilage ECM that affect biomechanical properties of the
joint tissues.6,7 Pathological changes in one joint tissue can affect
other tissues due to close biomechanical and biochemical association
and so it can be difficult to determine where the primary pathology is
initiated.8,9 There is growing evidence that subchondral bone al-
terations precede degeneration of the overlying articular cartilage in
some of the OA phenotypes2,10–12 and this sequence of pathological
events is thought to result from both biomechanical and biochemical
impact of subchondral bone perturbation on articular cartilage.11,13
Therefore, better understanding of the crosstalk between bone and
cartilage within healthy and diseased joints may help develop stra-
tegies to mitigate pathological changes or arrest OA progression.
Animal models that mimic symptoms and pathological features of
human OA are essential for studying molecular events underlying joint
tissue degeneration and developing interventions that could mitigate
disease progression.14–16 Various experimental animal models of OA
have been shown to be effective in inducing cartilage and subchondral
bone lesions characteristic of the late stage joint degeneration in
humans. However, induction of OA through surgical procedure or
enforced loading can induce rapid extensive changes (affecting
subchondral bone and cartilage, simultaneously), which make it difficult
to identify the early stages of disease development.15,17,18
Horses can provide a naturally occurring model of OA that re-
sembles human disease on the macroscopic, histological, and mole-
cular level through increased expression of proinflammatory
cytokines, and catabolic enzymes in the synovium, synovial fluid, and
articular cartilage.14,19,20 Joint disease in racehorses, associated with
regular, intensive exercise, provides a model for the study of re-
petitive stress induced microstructural changes in articular cartilage
and subchondral bone.21,22 A common site of overuse injuries in
racehorses are the palmar/plantar distal condyles of the third me-
tacarpal and metatarsal bones (Mc/MtIII). Pathologic lesions com-
monly referred to as palmar/plantar osteochondral disease (POD),
can progressively develop into whole‐joint disease, manifested by
pain with associated radiographic changes similar to human
OA.21,23–25 Specifically, the medial McIII condyle in the forelimb and
the lateral MtIII condyle in the hind limb have been shown to be
predisposed to POD. 24 This can be attributed to the variations in
loading of metacarpo‐ and metatarsophalangeal joints, due to mor-
phology of the distal condyles of Mc/MtIII.24 In early stages of POD,
subchondral bone abnormalities occur whilst the articular cartilage
remains grossly intact.21,24,25 Therefore, POD might provide a
plausible model for studying association between subchondral bone
injury and development of other OA changes in other tissues such as
articular cartilage and synovium.
The main aim of this study was to examine microstructural and
molecular changes in different joint tissues associated with different
stages of POD in racehorses. Furthermore, we aimed to compare
identified changes to those previously reported in OA. We hy-
pothesize that (i) subchondral bone is the predominantly affected
tissue in early POD and that development of cartilage and synovial
pathologic lesions follow the alterations in bone metabolic equili-
brium as POD progresses and (ii) POD could serve as a model for
early OA induced by repetitive mechanical stress, due to overlapping
structural and molecular phenotype in POD and early OA. The po-
tential impact of this study includes validation of POD as a model for
human OA research and improving knowledge of relations between
bone, cartilage, and synovium pathologic lesions concurrent with
development of OA.
2 | METHODS
2.1 | Sample collection and gross scoring
Metacarpo/metatarsophalangeal (Mc/MtPh) joints were collected
from Thoroughbred racehorses that were either in active race
training up to the time of death or had previously retired from active
race training at the Hong Kong Jockey Club between November 24,
2005 and March 25, 2009. All horses euthanized on welfare grounds
for reasons unrelated to the study were eligible for inclusion and
samples were collected at postmortem, within 30min of death.
Further details on sample and data collection and the racing popu-
lation at Hong Kong jockey club were previously described by
Pinchbeck et al.24 Mc/MtPh joints were examined by gross ob-
servation and assigned a POD score using the grading system de-
scribed by Barr et al.26 Briefly, grade 0 represents no gross
pathological lesions, grade 1—discolouration (bruising) of sub-
chondral bone with none or minimal disruption of articular cartilage,
grade 2—mild to moderate disruption of articular cartilage, and
grade 3—disruption/collapse of articular surface (Figure 1A).
2.2 | Histology
Histological scoring in all samples was performed by two in-
dependent observers blinded to the POD grade and the average of
the two scores recorded and used for statistical analysis. Sections
were obtained from the left medial distal metacarpal condyle and the
left lateral distal metatarsal. The condyle was cut with a band saw
then two sections each 2‐mm‐thick were cut with a saline cooled
diamond saw. Cartilage was dissected sharply with a scalpel and a
section of subchondral bone from the center of the sample at the
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anatomical site of POD measuring 15 × 15mm approximately was
dissected using a chisel. Examples of affected condyles are shown in
Figure 1A–C. Safranin O and Masson's trichrome staining of the
Mc/MtIII condyles were used to score cartilage pathologic lesions
using a modified Mankin score.27 Synovial membranes of the
Mc/MtPh joints harvested at postmortem were fixed in cold 4%
formaldehyde for at least 30min before being processed, paraffin‐
embedded, and cut into 10‐µm sections. Hematoxylin and eosin‐
stained sections of synovial membranes were used to assess the level
of synovitis. Three areas of each synovial membrane were evaluated
using scoring criteria designed by Krenn et al.28 and the average
score used for statistical analysis. Briefly, the synovitis score is the
sum of three features of chronic synovitis (enlargement of lining cell
layer, cellular density of synovial stroma, and leukocytic infiltrate),
each graded from 0 to 3. The total score is interpreted as follows:
0–1, no synovitis; 2–4, low‐grade synovitis; 5–9, high‐grade synovitis.
2.3 | RNA extraction from equine tissue
Cartilage, subchondral bone, and synovial membrane samples
were stored in RNAlater (Sigma‐Aldrich) at postmortem,
snap‐frozen in liquid nitrogen, and pulverized using a
Mikro‐Dismembrator (B. Braun Biotech International) at
2000 rpm for 4 min. Homogenized tissue was reconstituted in
1 ml of Tri‐reagent (Ambion) and total RNA was extracted using
the phenol‐chloroform method.29 RNA was purified using the
RNeasy Mini Kit (Qiagen) according to manufacturer's instruc-
tions, with on‐column DNase treatment (Qiagen). Purified RNA
was reconstituted in nuclease‐free water, quantified using a
Nanodrop ND‐100 spectrophotometer (Labtech) and RNA purity
was assessed based on the A260/A280 absorbance ratio and
samples with ratio above 1.8 were accepted for complementary
DNA (cDNA) preparation.
F IGURE 1 Examples of the different POD grades: (A) Parasagittal sections through the palmar/plantar aspect of the distal condyles of the
third metacarpal/metatarsal bone (Mc/MtIII); (B) histological images of sections cut from the samples similar to those above stained with
Safranin O and (C) Masson's trichrome stain. Scale bar = 1mm. (D) Histological scoring of articular cartilage and synovium samples from joints
with different POD grades [Color figure can be viewed at wileyonlinelibrary.com]
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2.4 | Reverse transcription and quantitative
real‐time polymerase chain reaction (PCR)
cDNA was synthesized from 1 µg of total RNA using the M‐MLV
reverse transcriptase, primed using random primers (Promega).
Quantitative real‐time PCR (qRT‐PCR) was performed on an ABI
7300 system using MESA Blue SYBR Green reagent (Eurogentec) to
examine gene expression in equine joint tissues (bone, cartilage, and
synovium) as described before.20 Gene expression levels were cal-
culated using the ‐Δ2 Ct method with glyceraldehyde 3‐phosphate
dehydrogenase as the reference gene, using the primers described in
Table S1. All primers were provided by Eurogentec. Genes evaluated
in all three tissues included marker of inflammation interleukin 1
beta (IL‐1β), ECM‐degrading enzymes: Matrix metalloproteinases
(MMP1, 3 and 13) and a disintegrin and metalloproteinase with
thrombospondin motifs 4 (ADAMTS4) as well as tissue inhibitor of
matrix metalloproteinase 1 (TIMP1). In bone and cartilage only, we
evaluated expression of ECM structural proteins: Aggrecan (ACAN),
biglycan (BGN), and collagens type I and II (COL1A2, COL2A1),
markers of ECM catabolism: ADAMTS12, MMP2, 9, 10, marker of
anabolism ADAMTS2, catabolism inhibitors (TIMP3 and 4) and OA
markers: vascular endothelial growth factor (VEGF), collagen type X
(COL10A1), and caspase 3 (CAS3). Additionally, expression of mar-
kers of osteoclast activity (receptor activator of nuclear factor κB
[RANK] and its ligand RANKL, tartare‐resistant acid phosphatase
[TRAP]), osteoblast differentiation (runt‐related transcription factor
2 [RUNX2], osteomodulin [OMD], osteoprotegerin [OPG]), bone
ECM catabolism (cathepsin K [CATK], MMP16, 23) and non-
collagenous ECM component bone sialoprotein (BSP) were evaluated
in the subchondral bone.
2.5 | Statistical analysis
All statistical analyses were performed using GraphPad Prism 6.0
(GraphPad Software). Due to the low sample number of POD
grade 3 samples, samples with POD grades of 3 were combined
with those of POD grade 2 for histology and gene expression data
analysis. Normalized gene expression data and histological scores
were subjected to the Shapiro–Wilk test for normality. Due to the
highly skewed distribution, the data were log‐transformed (LOG10
‐Δ2 Ct) and differences between the POD grades were analyzed with
one‐way analysis of variance with Tukey posthoc test. Gene da-
tasets that did not fill the criteria of normality (Shapiro–Wilk
p < 0.05) despite the log‐transformation were analyzed using
Kruskal–Wallis test with Dunn's test for multiple comparisons.
Spearman's correlation coefficient was calculated to investigate
relation between gene expression data and the cartilage Mankin
score. Benjamini‐Hochberg procedure with false discovery rate
below 0.05 was performed to correct for multiple comparisons
within each tissue type and corrected p < 0.05 considered
significant.
3 | RESULTS
Sixty‐four Mc/MtPh joints from 33 Thoroughbred horses aged 3–10
years (mean 6.3 ± 1.9 y) were used in the study. In 31 horses the left
McPh and MtPh joint were included in the study, whereas in two
horses only the left MtPh joint was included. Of all the joints ex-
amined, 34 were assigned to POD grade 0, 17 to POD grade 1, 9 to
POD grade 2, and 4 to POD grade 3.
3.1 | POD is associated with degradation of
cartilage but not synovitis
With increasing POD grade there was an increase in Mankin score
(p < 0.05). This suggests that articular cartilage damage was present
even at grade 1 POD (Figure 1D) and became more pronounced at
higher grades (p < 0.001). No difference was observed in histological
synovitis score across POD grades (Figure 1D).
3.2 | Gene expression in subchondral bone is
affected in early POD stage and correlates with
structural degradation of articular cartilage
Relative expression of ADAMTS12, BGN, and VEGF decreased
(p < 0.05), whereas COL1A2, COL2A1, and MMP1 increased
(p < 0.05) in subchondral bone from grade 1 POD compared with
grade 0 (Figure 2). Further changes in the expression of COL2A1,
MMP1, and VEGF were observed in POD grades 2 and 3. OPG ex-
pression decreased (p < 0.001) only in the POD grades 2 and
3 (Figure 2). Expression of MMP1, MMP10, and COL2A1 in the
subchondral bone was positively correlated with the cartilage
Mankin score, whereas BGN, CAS3, IL1β, MMP9, MMP16, OPG,
OMD, RANK, TIMP1, TIMP4, and VEGF decreased with articular
cartilage degradation (Figure 3). The direction of expression changes
relative to POD grade and Mankin score was consistent in the sig-
nificantly affected genes. No change in expression across POD
grades was shown for ACAN, ADAMTS4, and 5, BSP, CAS3, CATK,
COL10A1, IL1β, MMP2, MMP3, MMP9, MMP10, MMP13, MMP16,
MMP23. OCN, OMD, RANK, RANKL, TIMP1, TIMP3, TIMP4, and
TRAP (data not shown).
3.3 | Transcriptomic changes in articular cartilage
demonstrate altered ECM metabolism in POD grades
2 and 3
There was a significant increase in ADAMTS2, ACAN, and COL1A2
expression and decrease in ACAN, BGN, CAS3, and VEGF expression in
articular cartilage in POD‐affected joints. Expression of ACAN, BGN,
CAS3, and VEGF changed both with increasing POD grade (Figure 4)
and Mankin score (Figure 3). Expression levels of ADAMTS2 and
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MMP13 increased (p ≤ 0.01) and superficial zone protein 1 (SZP1) de-
creased (p ≤ 0.01) between healthy joints and POD grades 2 and 3.
TIMP4 decreased (p = 0.004) in POD grades 2 and 3 relative to grade 1
(Figure 4). ADAMTS12, COL2A1, COL10A1, IL1β, MMP1, MMP2,
MMP3, MMP9 and MMP10, and TIMP1 and TIMP3 showed no change
in expression across different POD grades (data not shown). There
were no changes in gene expression relative to POD grade and Mankin
score in synovium samples (data not shown).
4 | DISCUSSION
When studies are limited to tissues from severely diseased joints
with end‐stage joint disease, it is difficult to determine whether
changes in one tissue preceded changes in others, or if they devel-
oped independently in response to the same insult. The main
strength of this study was the inclusion of multiple tissues collected
from joints in different stages of naturally occurring traumatic joint
F IGURE 2 Expression of genes significantly (p < 0.05) affected by palmar/plantar osteochondral disease in subchondral bone from equine
metacarpo/metatarsophalangeal joints (n = 64)
F IGURE 3 Correlation between gene
expression and cartilage Mankin score in
subchondral bone, articular cartilage, and
synovium from equine metacarpo/
metatarsophalangeal joints (n = 64).
Horizontal lines represent confidence
intervals and vertical line Spearman's r
coefficient. Where correlation is not
presented, the gene was not investigated in
that tissue
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disease in which subchondral bone changes are generally considered
to be a significant initiating factor. The equine POD model allowed
investigation of the sequence of pathological events in different joint
tissues and analysis of potential relationships between them. Im-
portantly, we identified 17 joints representing the early phase of
POD, characterized by gross subchondral bone pathologic lesions
(“bruising”/discolouration24) with no or minimal grossly visible dis-
ruption of the overlying cartilage. Although macroscopically intact,
cartilage in grade 1 POD showed significantly higher Mankin score
and decreased gene expression of proteoglycans, ACAN and BGN,
VEGF and CAS3 compared to the grossly normal joints. That is
contrary to our hypothesis stating that grade 1 POD does not involve
significant pathological changes in articular cartilage. Increased
Mankin score is in line with the previous studies showing that
macroscopically normal cartilage in POD can show extensive levels
of microdamage.21,30 Decreased proteoglycan content is one of the
main characteristics of cartilage matrix loss in OA that results from
an imbalance between matrix synthesis and degradation by proteo-
lytic enzymes.31,32 Gene expression patterns similar to OA have been
reported in other early phase traumatic joint disorders33,34 and in
the low‐load sites of the OA‐affected joints,35 suggesting that mo-
lecular changes precede structural changes and may play causative
role in their development. Reduced expression of proteoglycans in
grade 1 POD correlates with histological signs of cartilage degen-
eration (Figure 3). CAS3 is one of the effector enzymes driving
chondrocyte apoptosis in OA upregulated by proinflammatory
cytokines,36 therefore, lack of change in IL1β expression in POD‐
affected cartilage in this study may explain the absence of CAS3
activation. Similarly, there was no change in expression of other
genes typically associated with OA: COL1A2, COL2A1, MMP13, and
COL10.20,34,35,37,37,38
In the more severe POD stages, where cartilage damage is evi-
dent on gross examination, we observed further increases in Mankin
score, decreased ACAN expression, and changes in expression
of other genes previously associated with spontaneous and
experimental OA (increase of ADAMTS2, COL1A2, MMP13, and
decrease of SZP1 and TIMP4).20,31,35,38–41 ADAMTS‐2 is a pro-
collagen N‐proteinase involved in collagen fibril formation and its
upregulation in this study coincided with an increase in COL1A2
expression, suggesting increased type I collagen synthesis. Normal
cartilage consists predominantly of type II collagen, although switch
to type I collagen production occurs in OA.31 Increased expression of
MMP13 is one of the hallmarks of OA due to its role as a marker of
chondrocyte hypertrophy and collagenase targeting mainly type II
collagen.42 Interestingly, increase of MMP13 expression occurred
only in POD grades 2 and 3, whereas in OA MMP13 upregulation is
present early in the disease onset.42 Though the underlying cause of
late MMP13 expression is unclear, it may be associated with the
absence of explicit inflammatory response in the analyzed joints as
proinflammatory cytokines are one of the main factors upregulating
MMP13 expression.43 Concurrent downregulation of TIMP4 in se-
vere POD suggests decreased protection of the ECM from MMP‐
mediated proteolysis. SZP1, also known as proteoglycan 4 or lubricin,
is a secreted glycoprotein that provides boundary lubrication be-
tween the joint surfaces. SZP1 is secreted mainly in the superficial
zone of articular cartilage and, therefore, its reduced expression in
POD grades 2 and 3 may be related to significant disruption/col-
lapse, or even loss of the cartilage surface (Figure 1). Altogether, the
significant changes in cartilage gene expression in severe POD in-
dicate a disrupted balance between anabolic/catabolic activity and
aberrant repair response (fibrillation) that corresponds with gradual
destruction of articular cartilage typical in the advanced OA. How-
ever, other phenotypic changes typically associated with OA, such as
expression of chondrocyte hypertrophy marker COL10 and enzymes
degrading other important ECM components—proteoglycans and gly-
coproteins (ADAMTS4, MMP3, and MMP9) were not observed. It is
worth noting that significant downregulation of proteoglycan anabolism
occurred before visible gross signs of cartilage compromise, highlighting
limitations of the macroscopic methods of joint health assessment
(arthroscopy) when assessing trauma‐induced disorders.
F IGURE 4 Expression of genes significantly affected by palmar/plantar osteochondral disease in articular cartilage from equine metacarpo/
metatarsophalangeal joints (n = 64)
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Gene expression profiles associated with joint degenerative
disease has been relatively well characterized in cartilage through
human and animal model studies.20,32,34,37,40,41 However, knowledge
of the transcriptomic changes affecting the subchondral bone is still
limited. In human OA research, subchondral bone sample collection
is usually limited to the end‐stage disease (joint replacement).44,45
Mouse model studies can offer insight into early stages of joint de-
genration but they are less suitable for gene expression analysis in
specific joint tissues due to their small size.38,39 Zhang et al.46 used
experimental rat model of posttraumatic osteoarthritis (PTOA) to
analyze the expression profile of the subchondral bone associated
with disease progression but without considering corresponding
changes in the articular cartilage. In this study, subchondral bone
showed more gene expression changes in grade 1 POD than the
corresponding cartilage samples (Figures 2 and 4), which fits within
the current understanding of POD as predominantly a disease of
subchondral bone. Structural integrity of the bone depends on the
coordinated response of osteoblasts that produce organic ECM
(mainly comprised of type I collagen) and drive its mineralization, and
bone‐degrading osteoclasts. In grade 1 POD we observed simulta-
neous increase in expression of COL1A2 and MMP1, the collagen‐
cleaving protease, suggesting an overall increase in collagen turn-
over. Expression of ADAMTS2 showed a declining trend in grade 1
POD followed by an increase in more severe POD stages and was
accompanied by decreased expression of BGN, a proteoglycan that
regulates collagen fibril organization.47 In POD grades 2 and 3 sub-
chondral bone showed decrease in expression of OPG which inhibits
osteoclastogenesis by disturbing the RANK/RANKL pathway, sug-
gesting increased activity of bone‐degrading cells. We also observed
marked decrease in expression of another ECM protease, MMP16, in
POD grades 2 and 3, however, this result may be biased due to there
being only a few samples of grade 2 and 3 POD subchondral bone
(n = 5, Figure 2). Uncoupled bone remodeling, with bone resorption
prevailing over bone formation, leads initially to the loss of bone
density, microfractures, and eventually collapse of the subchondral
bone and subsequent degradation of the overlying cartilage.22 In-
creased expression of COL2A1 observed in POD subchondral bone
(Figure 2) was previously reported in human end‐stage knee OA44
and rat experimental PTOA46 and could reflect attempted repair of
microfractures through callus formation and build‐up of trabecular
bone within bone marrow spaces that can be observed in equine
POD.22 It is possible that the mild cartilage damage identified in
grade 1 POD was partially caused by altered biomechanical prop-
erties of the subchondral bone undergoing intense remodeling in
response to mechanical overuse. Correlations between expression of
genes related to tissue remodeling (MMP1, MMP9, TIMP1/4, BGN,
OPG, RANK, and OMD) in the subchondral bone and the cartilage
Mankin score support our hypothesis that changes in bone metabolic
equilibrium are associated with articular cartilage degradation
in POD.
Downregulation of VEGF in grade 1 POD was demonstrated
simultaneously in cartilage and subchondral bone and negatively
correlated with the cartilage Mankin score. VEGF is an established
marker of clinical and preclinical OA associated with angiogenesis
and procatabolic response in the cartilage and sclerosis of the sub-
chondral bone.48 VEGF has been also shown to promote osteogenic
differentiation of bone marrow‐derived mesenchymal stromal cells
(BMSCs)49 yet the evidence on local VEGF expression in the sub-
chondral bone disease is limited. Decreased VEGF expression in POD
corresponds with lack of consistent activation of catabolic markers
and a decrease in osteoblastic marker of bone formation OPG, which
could potentially be attributed to decline in VEGF biological activity
in the bone. The study of human femoral joints with signs of cartilage
degeneration show unchanged VEGF expression in the subchondral
bone despite its upregulation in the overlying cartilage.50 The ex-
perimental induction of PTOA in rodents led to downregulation of
VEGF in subchondral bone46 and pooled joint tissues,38 similar to our
study. It is not clear if increase in VEGF expression in cartilage is
specific to the human OA or if animal models of traumatic joint
disease fail to replicate that phenotype.
POD has been previously shown to be positively correlated with
the presence of gross synovial pathologic lesions.24 In this study the
synovium histological score did not differ significantly between POD
groups, however, it did indicate low‐grade synovitis in all evaluated
joints, even in the absence of POD. Low level of synovial pathologic
changes in POD‐affected joints was supported by unchanged ex-
pression of IL1β and catabolic enzymes between POD grades. In-
flammation and hyperplasia of the synovial membrane in Mc/MtPh
joints is commonly observed in racehorses and attributed to re-
petitive mechanical overuse (hyperextension of Mc/MtPh joints
during high‐speed exercise). Synovitis can accelerate cartilage de-
gradation by release of cytokines, alarmins, and damage‐associated
molecular pattern molecules (DAMPS), whereas matrix molecules
resulting from cartilage damage stimulate synovitis. This cross‐talk
mediated by the synovial fluid is recognized as part of pathogenic
mechanism of OA.1 Lack of a significant effect of POD grade on
synovium histological score and gene expression level in this study
suggests that, unlike in OA, synovitis may play limited role in de-
velopment of POD and observed pathological lesions are more likely
to be secondary to subchondral bone and cartilage damage or direct
effect of repetitive mechanical loading on the joint capsule.
Some limitations to this study should be considered. Due to the
limited number of horses involved in the study, we included
Mc/MtPh joints obtained from the same animal. More than a half of
the studied horses obtained the same POD grades in the front and
hindlimb joint but the difference between POD score in McPh and
MtPh in the same horse could also range vastly across the POD
grades, suggesting joint reaction to repetitive loading can be highly
variable in individual animals or significant variation in loading of the
joints between front and hind limbs in the same animal. The incon-
sistency in the level of disease between animals, or even individual
joints in the same animal, is one of the main limitations of using
naturally occurring model of joint disease. Although naturally oc-
curring models are more likely to mimic pathological lesions identi-
fied in human joint degeneration,14,15 the time of disease
development is variable across individuals and, thus, the disease
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stage (acute, chronic) in samples collected postmortem can be diffi-
cult to determine. Additionally, limitations of the use of gross scoring
to identify severity of the lesions (POD grades) should be recognized.
It has been previously reported that microstructural damage can be
present in equine Mc/MtPh joints despite normal macroscopic
appearance.21,41 In this study, we aimed to account for that by using
two outcome measures to assess joint degeneration, gross joint
scoring and histological scoring of articular cartilage, and gene ex-
pression changes identified with regard to both measures were most
extensively discussed. However, it should be noted that subchondral
bone damage can be undetectable from external examination of the
joint surface at early POD stage and including histological scoring of
the subchondral bone would have been helpful to better define
disease severity. The small set of established gene markers of joint
degeneration used in this study could not provide exhaustive in-
formation about all molecular processes relevant for the disease
development, however, it allowed comparison of equine POD to
multiple clinical and experimental OA studies in the literature. De-
spite these limitations, our work provides a rare insight into tran-
scriptomic changes in three different joint tissues at different stages
of a naturally occurring degenerative joint disease and their sig-
nificance in relation to micro‐ and macrostructural signs of joint
pathology.
In conclusion, gene expression analysis in the subchondral bone
in POD suggest changes in bone turnover that likely leads to ar-
ticular cartilage damage, however, changes in cartilage micro-
structure and gene expression are detectable even at the early stage
of disease. Despite altered regulation of several well‐established
markers of OA (MMP13 and ACAN), limited activation of proin-
flammatory and catabolic genes suggests that POD has a distinct
molecular phenotype compared to PTOA and, therefore, does not
constitute an accurate model for studying OA pathogenesis. Tran-
scriptional response of articular cartilage at stages where only mi-
croscopic features of cartilage degeneration were detectable
supports the putative role of biomechanical and biochemical re-
lationships between subchondral bone and cartilage in development
of this degenerative joint disease.
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